2,156
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Syringeable atorvastatin loaded eugenol enriched PEGylated cubosomes in-situ gel for the intra-pocket treatment of periodontitis: statistical optimization and clinical assessment

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Article: 2162159 | Received 28 Oct 2022, Accepted 19 Dec 2022, Published online: 05 Jan 2023

References

  • Aboud HM, Hassan AH, Ali AA, Abdel-Razik ARH. (2018). Novel in situ gelling vaginal sponges of sildenafil citrate-based cubosomes for uterine targeting. Drug Deliv 25:1–15.
  • Agrali B, Kuru BE, Yarat A, Kuru L. (2016). Evaluation of gingival crevicular fluid transforming growth factor-β1 level after treatment of intrabony periodontal defects with enamel matrix derivatives and autogenous bone graft: a randomized controlled clinical trial. Niger J Clin Pract 19:535–43.
  • Ahmad N, Ahmad FJ, Bedi S, et al. (2019). A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitis. Saudi Pharm J 27:778–90.
  • Albash R, Abdellatif MM, Hassan M, Badawi NM. (2021). Tailoring terpesomes and leciplex for the effective ocular conveyance of moxifloxacin hydrochloride (Comparative assessment): in-vitro, ex-vivo, and in-vivo evaluation. Int J Nanomedicine 16:5247–63.
  • Albash R, Yousry C, Al-Mahallawi AM, Alaa-Eldin AA. (2021). Utilization of PEGylated cerosomes for effective topical delivery of fenticonazole nitrate: in-vitro characterization, statistical optimization, and in-vivo assessment. Drug Deliv 28:1–9.
  • Al-Mahallawi AM, Khowessah OM, Shoukri RA. (2014). Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: in-vitro optimization, ex-vivo permeation studies, and in-vivo assessment. Int J Pharm 472:304–14.
  • Asadinezhad S, Khodaiyan F, Salami M, et al. (2019). Effect of different parameters on orange oil nanoemulsion particle size: combination of low energy and high energy methods. Food Measure 13:2501–9.
  • Aslroosta H, Yaghobee S, Akbari S, Kanounisabet N. (2021). The effects of topical erythropoietin on non-surgical treatment of periodontitis: a preliminary study. BMC Oral Health 21:1–8.
  • Balli U, Keles GC, Cetinkaya BO, et al. (2014). Assessment of vascular endothelial growth factor and matrix metalloproteinase-9 in the periodontium of rats treated with atorvastatin. J Periodontol 85:178–87.
  • Bansal M, Mittal N, Yadav SK, et al. (2018). Periodontal thermoresponsive, mucoadhesive dual antimicrobial loaded in-situ gel for the treatment of periodontal disease: preparation, in-vitro characterization and antimicrobial study. J Oral Biol Craniofac Res 8:126–33.
  • British Pharmacopoeia Commission. (2011). British pharmacopoeia 2011. The Department Of Health. Social Services and Public Safety.
  • Bruschi ML, Jones DS, Panzeri H, et al. (2007). Semisolid systems containing propolis for the treatment of periodontal disease: in vitro release kinetics, syringeability, rheological, textural, and mucoadhesive properties. J Pharm Sci 96:2074–89.
  • Carter HG, Barnes P. (1974). The Gingival Bleeding Index. J Periodontol 45(11):801–805.
  • Chen Y, Cheng G, Hu R, et al. (2019). A nasal temperature and pH dual-responsive in situ gel delivery system based on microemulsion of huperzine a: formulation, evaluation, and in vivo pharmacokinetic study. AAPS PharmSciTech 20:1–12.
  • Chen Y, Ma P, Gui S. (2014). Cubic and hexagonal liquid crystals as drug delivery systems. Biomed Res Int 2014:815981.
  • Choudhary A, Rana AC, Aggarwal G, et al. (2012). Development and characterization of an atorvastatin solid dispersion formulation using skimmed milk for improved oral bioavailability. Acta Pharm Sin B 2:421–8.
  • Dahiya P, Kamal R. (2013). Hyaluronic acid: a boon in periodontal therapy. N Am J Med Sci 5:309–15.
  • Dong W, Su X, Xu M, et al. (2018). Preparation, characterization, and in vitro/vivo evaluation of polymer-assisting formulation of atorvastatin calcium based on solid dispersion technique. Asian J Pharm Sci 13:546–54.
  • Eick S, Renatus A, Heinicke M, et al. (2013). Hyaluronic acid as an adjunct after scaling and root planing: a prospective randomized clinical trial. J Periodontol 84:941–9.
  • Elakkad YE, Younis MK, Allam RM, et al. (2021). Tenoxicam loaded hyalcubosomes for osteoarthritis. Int J Pharm 601:120483.
  • Eldeeb AE, Salah S, Ghorab M. (2019). Formulation and evaluation of cubosomes drug delivery system for treatment of glaucoma: ex-vivo permeation and in-vivo pharmacodynamic study. J Drug Delivery Sci Technol 52:236–47.
  • El-Leithy ES, Makky AM, Khattab AM, Hussein DG. (2018). Optimization of nutraceutical coenzyme Q10 nanoemulsion with improved skin permeability and anti-wrinkle efficiency. Drug Dev Ind Pharm 44:316–28.
  • Elnaggar YSR, Etman SM, Abdelmonsif DA, Abdallah OY. (2015). Novel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer’s disease: pharmaceutical, biological, and toxicological studies. Int J Nanomedicine 10:5459–73.
  • Erol İ, Üstündağ Okur N, Orak D, et al. (2020). Tazarotene-loaded in situ gels for potential management of psoriasis: biocompatibility, anti-inflammatory and analgesic effect. Pharm Dev Technol 25:909–18.
  • Fam NP, Verma S, Kutryk M, Stewart DJ. (2003). Clinician guide to angiogenesis. In Circulation 108:2613–8.
  • Fujioka-Kobayashi M, Müller HD, Mueller A, et al. (2017). In vitro effects of hyaluronic acid on human periodontal ligament cells. BMC Oral Health 17(1):1–12.
  • Gaballa SA, el Garhy OH, Moharram H, Abdelkader H. (2020). Preparation and evaluation of cubosomes/cubosomal gels for ocular delivery of beclomethasone dipropionate for management of uveitis. Pharm Res 37:1–23.
  • Gad HA, Kamel AO, Ezzat OM, et al. (2017). Doxycycline hydrochloride-metronidazole solid lipid microparticles gels for treatment of periodontitis: development, in-vitro and in-vivo clinical evaluation. Expert Opin Drug Deliv 14:1241–51.
  • Gumus P, Huseyinalemdaroglu B, Buduneli N. (2016). The role of oxidative stress in the interaction of periodontal disease with systemic diseases or conditions. Oxid Antioxid Med Sci 5:33.
  • Haffajee AD, Socransky SS, Goodson JM. (1992). Subgingival temperature (I). Relation to baseline clinical parameters. J Clin Periodontol 19:401–8.
  • Hamed R, Al-Adhami Y, Abu-Huwaij R. (2019). Concentration of a microemulsion influences the mechanical properties of ibuprofen in situ microgels. Int J Pharm 570:118684.
  • Hau H, Rohanizadeh R, Ghadiri M, Chrzanowski W. (2014). A mini-review on novel intraperiodontal pocket drug delivery materials for the treatment of periodontal diseases. Drug Deliv Transl Res 4:295–301. (Vol. Issue Springer Verlag.
  • Hegazy D, Tag R, Habib BA. (2022). Statistical sequential experimentation: preliminary mixed factorial design, I-optimal mixture design then finally novel design space expansion for optimization of tazarotene cubosomes. Int J Nanomedicine 17:1069–86.
  • Huang J, Peng T, Li Y, et al. (2017). Ocular cubosome drug delivery system for timolol maleate: preparation, characterization, cytotoxicity, ex vivo, and in vivo evaluation. AAPS PharmSciTech 18:2919–26.
  • Jadhav BK, Khandelwal KR, Ketkar AR, Pisal SS. (2004). Formulation and evaluation of mucoadhesive tablets containing eugenol for the treatment of periodontal diseases. Drug Dev Ind Pharm 30:195–203.
  • Jin X, Zhang ZH, Sun E, et al. (2013). Enhanced oral absorption of 20(S)-protopanaxadiol by self-assembled liquid crystalline nanoparticles containing piperine: in vitro and in vivo studies. Int J Nanomedicine 8:641–52.
  • Johnson A, Kong F, Miao S, et al. (2020). Therapeutic effects of antibiotics loaded cellulose nanofiber and κ-carrageenan oligosaccharide composite hydrogels for periodontitis treatment. Sci Rep 10(1):1–23.
  • Kapil H, Suresh DK, Bathla SC, Arora KS. (2018). Assessment of clinical efficacy of locally delivered 0.2% Thymoquinone gel in the treatment of periodontitis. Saudi Dent J 30:348–54.
  • Karataş A, Yüksel N, Baykara T. (2005). Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol. Farmaco 60:777–82.
  • Kim Y-H, Park B-S. (2015). Antioxidant effect of eugenol in human periodontal ligament fibroblasts. Korean J Phys Anthropol 28:45.
  • Kumari M, Martande SS, Pradeep AR. (2017). Subgingivally delivered 1.2% atorvastatin in the treatment of chronic periodontitis among smokers: a randomized, controlled clinical trial. J Invest Clin Dent 8:e12213.
  • Liao YH, Jones SA, Forbes B, et al. (2005). Hyaluronan: pharmaceutical characterization and drug delivery. Drug Deliv 12:327–42.
  • Mansour M, Elmowafy E, Gad HA. (2021). Intranasal versus intraperitoneal Myrj 59-stabilized cubosomes: a potential armamentarium of effective anti-diabetic therapy. Colloids Surf B Biointerfaces 199:111534.
  • Mei L, Huang X, Xie Y, et al. (2017). An injectable in situ gel with cubic and hexagonal nanostructures for local treatment of chronic periodontitis. Drug Deliv 24:1148–58.
  • Mesa FL, Aneiros J, Cabrera A, et al. (2002). Antiproliferative effect of topic hyaluronic acid gel. Histol Histopathol 17(3):747–53.
  • Mohsen AM, Younis MM, Salama A, Darwish AB. (2021). Cubosomes as a potential oral drug delivery system for enhancing the hepatoprotective effect of coenzyme Q10. J Pharm Sci 110:2677–86.
  • Moore JW, Flanner HH. (1996). Mathematical comparison of curves with an emphasis on in vitro release profiles. Pharm Tech 20(6):64–74.
  • Morsi N, Ghorab D, Refai H, Teba H. (2016). Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery. Int J Pharm 506:57–67.
  • Mou J, Liu Z, Liu J, et al. (2019). Hydrogel containing minocycline and zinc oxide-loaded serum albumin nanopartical for periodontitis application: preparation, characterization and evaluation. Drug Deliv 26:179–87.
  • Musallam AA, Mahdy MA, Elnahas HM, Aldeeb RA. (2022). Optimization of mirtazapine loaded into mesoporous silica nanostructures via Box-Behnken design: in-vitro characterization and in-vivo assessment. Drug Deliv 29:1582–94. https://doi.org/10.1080/10717544.2022.2075985
  • Nasr M, Younes H, Abdel-Rashid RS. (2020). Formulation and evaluation of cubosomes containing colchicine for transdermal delivery. Drug Deliv Transl Res 10:1302–13.
  • Nasra MMA, Khiri HM, Hazzah HA, Abdallah OY. (2017). Formulation, in-vitro characterization and clinical evaluation of curcumin in-situ gel for treatment of periodontitis. Drug Deliv 24:133–42.
  • Nithya R, Jerold P, Siram K. (2018). Cubosomes of dapsone enhanced permeation across the skin. J Drug Delivery Sci Technol 48:75–81.
  • Okur NÜ, Yağcılar AP, Siafaka PI. (2020). Promising polymeric drug carriers for local delivery: the case of in situ gels. Curr Drug Deliv 17:675–93.
  • Opdyke DLJ. (1975). MONOGRAPHS monographs on fragrance raw materials*. Food Chem Toxicol 13:815–17.
  • Pernin A, Bosc V, Maillard MN, Dubois-Brissonnet F. (2019). Ferulic acid and eugenol have different abilities to maintain their inhibitory activity against Listeria monocytogenes in emulsified systems. Front Microbiol 10:137.
  • Pradeep AR, Kumari M, Rao NS, et al. (2013). Clinical efficacy of subgingivally delivered 1.2% atorvastatin in chronic periodontitis: a randomized controlled clinical trial. J Periodontol 84:871–9.
  • Rapalli VK, Sharma S, Roy A, Singhvi G. (2021). Design and dermatokinetic evaluation of Apremilast loaded nanostructured lipid carriers embedded gel for topical delivery: a potential approach for improved permeation and prolong skin deposition. Colloids Surf B Biointerfaces 206:111945.
  • Risaliti L, Kehagia A, Daoultzi E, et al. (2019). Liposomes loaded with Salvia triloba and Rosmarinus officinalis essential oils: in vitro assessment of antioxidant, antiinflammatory and antibacterial activities. J Drug Delivery Sci Technol 51:493–8.
  • Ruan H, Yu Y, Liu Y, et al. (2016). Preparation and characteristics of thermoresponsive gel of minocycline hydrochloride and evaluation of its effect on experimental periodontitis models. Drug Deliv 23:525–31.
  • Salem HF, Nafady MM, Ewees MGED, et al. (2022). Rosuvastatin calcium-based novel nanocubic vesicles capped with silver nanoparticles-loaded hydrogel for wound healing management: optimization employing Box–Behnken design: in vitro and in vivo assessment. J Liposome Res 32:45–61.
  • Shaheen MA, Elmeadawy SH, Bazeed FB, et al. (2020). Innovative coenzyme Q10-loaded nanoformulation as an adjunct approach for the management of moderate periodontitis: preparation, evaluation, and clinical study. Drug Deliv Transl Res 10:548–64.
  • Shahraeini SS, Akbari J, Saeedi M, et al. (2020). Atorvastatin solid lipid nanoparticles as a promising approach for dermal delivery and an anti-inflammatory agent. AAPS PharmSciTech 21:1–10.
  • Singla P, Garg S, Bhatti R, et al. (2020). Solubilization of hydrophobic drugs clozapine and oxcarbazepine in the lower and higher molecular weight pluronic mixed micelles-a physicochemical, In vitro release and In vitro anti-oxidant study. J Mol Liq 317:113816.
  • Srivastava M, Kohli K, Ali M. (2016). Formulation development of novel in situ nanoemulgel (NEG) of ketoprofen for the treatment of periodontitis. Drug Deliv 23:154–66.
  • Surve SM, Acharya AB, Thakur SL. (2015). Efficacy of subgingivally delivered atorvastatin and simvastatin as an adjunct to scaling and root planing. Drug Metab Pers Ther 30:263–9.
  • Tahamtan S, Shirban F, Bagherniya M, et al. (2020). The effects of statins on dental and oral health: a review of preclinical and clinical studies. J Transl Med 18:1–42.
  • Vikram V, Ramakrishnan T, Anilkumar K, Ambalavanan N. (2015). Changes in transforming growth factor-β1 in gingival crevicular fluid of patients with chronic periodontitis following periodontal flap surgery. J Clin Diagn Res 9:ZC13–ZC16.
  • Yeom DW, Son HY, Kim JH, et al. (2016). Development of a solidified self-microemulsifying drug delivery system (S-SMEDDS) for atorvastatin calcium with improved dissolution and bioavailability. Int J Pharm 506:302–11.
  • Younes NF, Abdel-Halim SA, Elassasy AI. (2018a). Solutol HS15 based binary mixed micelles with penetration enhancers for augmented corneal delivery of sertaconazole nitrate: optimization, in vitro, ex vivo and in vivo characterization. Drug Deliv 25:1706–17.
  • Younes NF, Abdel-Halim SA, Elassasy AI. (2018b). Corneal targeted Sertaconazole nitrate loaded cubosomes: preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies. Int J Pharm 553:386–97.
  • Younes NF, el Assasy AEHI, Makhlouf AIA. (2021). Microenvironmental pH-modified Amisulpride-Labrasol matrix tablets: development, optimization and in vivo pharmacokinetic study. Drug Deliv Transl Res 11:103–17.
  • Younes NF, Habib BA. (2022). Augmented local skin accumulation efficiency of sertaconazole nitrate via glycerosomal hydrogel: formulation, statistical optimization, ex vivo performance and in vivo penetration. J Drug Delivery Sci Technol 72:103364.